1. Introduction {#sec1-ijms-20-03459}
===============

Plant pathogenic fungi negatively affects a large number of important fruits during the growing season and throughout post-harvest storage that cause serious losses of yield and quality for a number of fruits worldwide \[[@B1-ijms-20-03459],[@B2-ijms-20-03459]\]. For instance, 10% to 30% of citrus fruit loss is caused by blue mold disease throughout the world \[[@B3-ijms-20-03459]\]. One of the most usual post-harvest fungal diseases of citrus fruits is blue mold caused by *Penicillium italicum*. Agricultural practices and biological measures only provided limited relief against this disease. Thus, a large number of commercial fungicides were used to control the blue mold \[[@B4-ijms-20-03459]\]. Application of numerous chemical synthetic fungicides is the major method to control *P. italicum* of citrus. However, the application of synthetic fungicides has been increasingly restricted because of a series of severe issues that arose from these chemical synthetic fungicides, such as residues of toxic compounds, environmental pollution, pathogen resistant development, and health hazard problems \[[@B4-ijms-20-03459]\]. Compared to chemical synthetic antifungal agents, natural compounds are generally found to be safe due to less toxicity or no toxicity. It is, therefore, urgent to explore novel effective and non-toxic or less toxic antifungal agents with new modes of action. The numbers of research studies have reported the antifungal effects of natural antifungal compounds for restraining postharvest blue mold caused by *P. italicum* \[[@B3-ijms-20-03459],[@B5-ijms-20-03459],[@B6-ijms-20-03459],[@B7-ijms-20-03459],[@B8-ijms-20-03459]\].

A 2-methoxy-1,4-naphthoquinone (MNQ) ([Figure 1](#ijms-20-03459-f001){ref-type="fig"}) is a naturally occurring phytochemical isolated from a traditional Chinese medicinal plant, *Impatiens balsamina* Linn \[[@B9-ijms-20-03459]\]. Previous studies showed that MNQ possessed diverse biological activities including anti-cancer \[[@B10-ijms-20-03459]\], anti-metastatic \[[@B11-ijms-20-03459]\] , and anti-bacterial \[[@B12-ijms-20-03459]\] properties. However, there is still a lack of more data about the antifungal activities of this 1,4-naphthoquinone derivative \[[@B10-ijms-20-03459],[@B13-ijms-20-03459]\]. Nonetheless, our present investigation indicated that the MNQ had a significant anti-fungal activity against *P*. *italicum* as a promising anti-fungal precursor. However, the possible antifungal molecular mechanisms of MNQ *P. italicum* have not been investigated yet. Thus, the possible mechanisms involving changes of morphological, changes of proteins and pathways, and the energy deficit in *P. italicum* should be further investigated because the biomolecules functionally govern cellular processes and, ultimately, dictate the biological phenotypes, proteins that are primary targets of drug discovery \[[@B11-ijms-20-03459]\], and the differentially expressed proteins (DEPs). These offer clues on the proteins and pathways affected by a drug treatment \[[@B14-ijms-20-03459]\].

In this study, we aimed to investigate the modulatory effects of MNQ toward the *P. italicum* proteome by using a label-free quantitative proteomic approach to identify proteins with significantly changed expression profiles, to confirm their functions in the MNQ-treated *P. italicum*. Moreover, three selected proteins related to oxidative stress and polycyclic aromatic hydrocarbon degradation were also confirmed using parallel reaction monitoring (PRM) analysis. Ultimately, these findings will contribute to our further understanding of the possible new molecular action of MNQ against *P. italicum*.

2. Results {#sec2-ijms-20-03459}
==========

2.1. Effects of MNQ on P. italicum {#sec2dot1-ijms-20-03459}
----------------------------------

The inhibitory effect of MNQ on *P. italicum* was carried out using a mycelial growth rate method. As shown in [Table 1](#ijms-20-03459-t001){ref-type="table"}, MNQ at 1.0 μg/mL showed a blank antifungal activity against *P. italicum*. When the concentrations of MNQ are at 2.0, 4.0, and 6.0 μg/mL, MNQ displayed a high anti-fungal activity against *P. italicum*. Among them, MNQ at 6.0 μg/mL exhibited a stronger antifungal activity against *P. italicum*. As depicted in [Figure 2](#ijms-20-03459-f002){ref-type="fig"}, *P. italicum* mycelial growth showed a declining tendency with the increasing concentrations of MNQ. The MIC value was defined as the lowest MNQ concentration that completely inhibited the growth of *P. italicum* after 48 hours of incubation at 28 °C \[[@B15-ijms-20-03459]\]. MNQ showed a significant anti-*P. italicum* effect with an MIC value of 5.0 µg/mL ([Figure S1](#app1-ijms-20-03459){ref-type="app"}).

2.2. Light Microscopy Observation {#sec2dot2-ijms-20-03459}
---------------------------------

Light microscopy of the control *P. italicum* mycelia grown on PDB showed a normal, filamentous, and homogeneous mycelial morphology ([Figure 3](#ijms-20-03459-f003){ref-type="fig"}a). By contrast, the mycelia treated with 2.0 μg/mL of MNQ showed a massive distortion and abnormal enlargement of the growing point. Meanwhile, [Figure 3](#ijms-20-03459-f003){ref-type="fig"}b,c showed that the MNQ-treated mycelia significantly altered the mycelial morphology of *P. italicum*, including breakage and malformation (highlighted with blue arrows). Clearly, MNQ treatment resulted in the damage to *P. italicum* mycelia (magnification is 400 times).

2.3. Label-Free Proteomic Based Protein Identification in the Treatment Group and Control Group {#sec2dot3-ijms-20-03459}
-----------------------------------------------------------------------------------------------

Quantitative proteomic analysis of mycelia samples from the treatment group and control group was performed using the label-free proteomic analysis method. In total, 3037 proteins were identified with a 1% false discovery rate (FDR) ([Table S1](#app1-ijms-20-03459){ref-type="app"}). [Figure 4](#ijms-20-03459-f004){ref-type="fig"} shows the total numbers of differentially expressed proteins in the treatment group and the control group. [Figure 4](#ijms-20-03459-f004){ref-type="fig"}a shows the volcano plot for the differentially expressed proteins (DEPs) in the treatment group and the DEPs (up-regulated \> 2.0-fold or down-regulated \< 0.5-fold, *p* \< 0.05) highlight in a pink color. All the DEPs are listed in [Table 2](#ijms-20-03459-t002){ref-type="table"}. The Venn diagram in [Figure 4](#ijms-20-03459-f004){ref-type="fig"}b shows the number of proteins that are unique to the treatment group or the control group. As shown in [Figure 4](#ijms-20-03459-f004){ref-type="fig"}b, there were 2854 proteins both expressed in the treatment group and the control group, 139 proteins were unique to the treatment group when compared to 44 for the control group. A total of 129 proteins showed significant changes in expression. Compared with the control group, 45 proteins (19 up-regulated and 26 down-regulated) were significantly changed in abundance in the treatment group ([Table 3](#ijms-20-03459-t003){ref-type="table"}). Meanwhile, 67 newly arising proteins were identified in the treatment group, but not found in the control group, and 17 proteins were undetectable in the treatment group while observed in the control group. Hierarchical cluster analysis was performed for all the DEPs for the treatment group and the control group ([Figure 5](#ijms-20-03459-f005){ref-type="fig"}). As shown in [Figure 5](#ijms-20-03459-f005){ref-type="fig"}, it was easy to note that the differentially expressed proteins in the treatment group did not cluster together with the one in the control group.

2.4. Functional Annotation of Proteins {#sec2dot4-ijms-20-03459}
--------------------------------------

To deduce the functionality and biological processes associated with the identified DEPs in the treatment group and control group, gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichments were performed. The GO and KEGG annotation of the identified proteins were carried out to comprehensively reflect the biological functions and significance of these proteins in various life activities. Functional annotation of all proteins obtained from the treatment group and control group revealed a sum of 129 differential proteins. Of these, 83 proteins were sub-categorized into 23 hierarchically-structured GO classifications. Twenty-eight proteins identified for differential metabolic pathways by KEGG were sub-categorized into 60 classifications ([Figure 6](#ijms-20-03459-f006){ref-type="fig"}).

### 2.4.1. Gene Ontology (GO) Annotation {#sec2dot4dot1-ijms-20-03459}

GO annotation gives a priority for a systematical analysis of the protein properties of targeted proteins \[[@B16-ijms-20-03459]\]. In order to get a detailed description, GO was further categorized into three components e.g., biological process (BP), cellular component (CC), and molecular function (MF). The GO analysis revealed that the identified DEPs were associated with different molecular and biological processes. Most of the identified DEPs were involved in molecular function (47%). Meanwhile 27% DEPs were involved in the cellular component and 26% DEPs were involved in the biological process ([Figure 7](#ijms-20-03459-f007){ref-type="fig"}). The biological process was found to be highly enriched in the cellular process (35%) and the metabolic process (32%). At the cellular component level, the identified DEPs were linked to the membrane (19%), membrane part (19%), cell (18%), cell part (17%), and organelle (14%). Similarly, catalytic activity (53%) and binding (38%) were most significantly expressed in the molecular function. Altogether, these results suggest that many proteins in *P. italicum* under MNQ treated might be involved in different metabolic and cellular processes and localize in different cell parts and organelles.

### 2.4.2. Metabolic Pathway Annotation {#sec2dot4dot2-ijms-20-03459}

The DEPs coordinate with each other to express their biological behavior. Thus, the pathway-based annotation broadens further exploration of their biological functions. The pathway analysis can determine important biochemical, ametabolic, and signaling pathways regulated by proteins. The KEGG database results indicated that the differential proteins participated in a total of 60 signaling pathways ([Table 4](#ijms-20-03459-t004){ref-type="table"}). From these, the top 10 metabolic pathways were dioxin degradation, polycyclic aromatic hydrocarbon degradation, linoleic acid metabolism, betalain biosynthesis, sphingolipid metabolism, mineral absorption, longevity regulating pathway, pentose and glucuronate interconversions, MAPK signaling pathway--yeast, and the mRNA surveillance pathway ([Figure S2](#app1-ijms-20-03459){ref-type="app"}).

2.5. PRM Verification of DEPs {#sec2dot5-ijms-20-03459}
-----------------------------

The PRM assay was applied to validate the selected proteins obtained in the label-free quantitative proteomics analysis. Only proteins that possessed unique peptide sequences were selected for PRM analysis because the signature peptides for target proteins must exhibit uniqueness \[[@B17-ijms-20-03459]\]. Three of the proteins were selected at random for further verification. The PRM results showed that the abundance of nitroreductase family protein (from *Metarhizium brunneum*, identity 90.4%), cytochrome P450, and monooxygenase changed in a consistent way with the proteomics results ([Table 5](#ijms-20-03459-t005){ref-type="table"}). In general, three of the candidate proteins detected by PRM had changes consistent with the proteomics results.

3. Discussion {#sec3-ijms-20-03459}
=============

3.1. Effects of MNQ on the Mycelial Growth and Morphology of P. italicum {#sec3dot1-ijms-20-03459}
------------------------------------------------------------------------

For a pathogen, a drug may prove fatal depending on the level of drug exposure (time and concentration). Our present study showed that the mycelial growths of *P*. *italicum* were decreased in a dose-dependent manner. MNQ treatment significantly reduced the mycelial growth of *P*. *italicum* ([Table 1](#ijms-20-03459-t001){ref-type="table"}). However, microorganisms are extremely adaptable because their lifestyles require the swift phenotypic adaptation with a variety of changing environmental factors \[[@B18-ijms-20-03459]\]. If the pathogenic fungi are not inhibited or killed by drug exposure, its will render the organism less susceptible to drug toxicity because the drug challenge may be met by adaptive responses \[[@B19-ijms-20-03459]\].

Microscopic analyses showed a clear difference between the treatment group and control group mycelia of *P. italicum*. The MNQ (2.0 μg/mL) treated mycelia were inflated at the growing point. Meanwhile, those mycelia exposed to MNQ treatment were malformation and collapsed. The present study revealed that the prominence of mycelia decreased the mycelia grew, and the changes of mycelia may have been attributed to amplifying membrane permeability. It would result in the swelling of the mycelial tips, collapse of the cell wall, leakage of cell constituents, and, ultimately, mycelia growth was restricted or cell death ([Figure 2](#ijms-20-03459-f002){ref-type="fig"} and [Figure 3](#ijms-20-03459-f003){ref-type="fig"}). In a word, microscopy observation showed that MNQ resulted in an irregular variation of *P. italicum* mycelia, which indicates that the inhibitory effect of MNQ on *P. italicum* could be linked with membrane permeability changes modulated by the membrane lipid composition. Ergosterol is one of the main lipid molecules in the fungi cell membrane. It regulates membrane fluidity, permeability, and the activity of many membrane-bound enzymes \[[@B20-ijms-20-03459]\]. Furthermore, the inhibition on ergosterol synthesis may result in changes of the cell wall structure and morphology \[[@B21-ijms-20-03459]\]. Under the stress of the MNQ, it is more difficult for *P. italicum* to maintain cell wall integrity or to produce a new cell wall. The change of mycelial morphology suggested that MNQ can play an important role in destroying *P. italicum* viability.

3.2. Proteins Related to Energy Generation and the NADPH Supply and Other Functions {#sec3dot2-ijms-20-03459}
-----------------------------------------------------------------------------------

Proteomics results suggested that MNQ elicited a cellular response and some peculiar mechanisms that were very different between the treatment group and control group due to MNQ exposure is an environmental stress to a pathogen who must raise the response \[[@B19-ijms-20-03459]\]. A fitting response to these adversities that might be caused by MNQ includes physiological and developmental changes, reprogramming of the resistance gene or proteins, the affection of energy generation, and the NADPH supply. Proteomics analysis revealed that MNQ treatment significantly up-regulated four energy generation related proteins including the mitochondrial carrier protein, glycoside hydrolase, acyl-CoA dehydrogenase, and ribulose-phosphate 3-epimerase ([Table 2](#ijms-20-03459-t002){ref-type="table"}). The results showed that the mitochondrial carrier protein increased by 2.51-fold in the treatment group. The increase of the mitochondrial carrier protein may lead to accelerated material transport, which suggests that the biosynthesis and degradation rate in the mitochondria of cells were accelerated \[[@B22-ijms-20-03459]\] because mitochondria play an important metabolic role in eukaryotes that generate the energy in the form of ATP \[[@B23-ijms-20-03459]\]. In addition, the acyl-CoA dehydrogenase (ACAD) can catalyze α, β-acyl-CoA esters dehydrogenation in the amino acid, and fatty acid catabolism \[[@B24-ijms-20-03459]\]. Both acyl-CoA oxidases and ACAD that is bona fide peroxisomal proteins in fungi are the basic enzymatic repertoire of peroxisomes \[[@B25-ijms-20-03459]\]. The increase of ACAD indicated that fatty acid and amino acid catabolism were active in the treatment group.

Meanwhile, there were five proteins up-regulated including enolase, pyruvate carboxylase, ATP-dependent 6-phosphofructokinase, malate synthase, and phosphoenolpyruvate carboxykinase that play a role in the NADPH supply ([Table S1](#app1-ijms-20-03459){ref-type="app"}). Enolase, as a significant metabolic intermediate for ATP and NADH production, is a ubiquitous glycolytic enzyme involved in the glycolysis and gluconeogenesis pathways, and it catalyzes the reversible dehydration conversion of 2-phosphoglyceric acid into phosphoenolpyruvate \[[@B26-ijms-20-03459]\]. In our study, the up-regulated enolase may play an important role in energy generation and cell apoptosis. NADPH plays a vital role in fatty acid synthesis. The change of NADPH may affect the cell integrity because phospholipids are the main content factors of the cell membrane \[[@B27-ijms-20-03459]\]. Some of these enzymes including malic enzyme (ME) and 6-phosphogluconate dehydrogenase (6PGDH) also play important roles in generating NADPH/NADH. ME is a primary source of NADPH for de novo lipid biosynthesis and desaturation. Meanwhile, 6PGDH is one of the enzymes that catalyzes reactions generating NADPH in the oxidative pentose phosphate pathway \[[@B28-ijms-20-03459]\]. We found that ME and 6PGDH increased 1.03-fold and 1.15-fold, but the expression difference was not consistent with the significance criteria ([Table S1](#app1-ijms-20-03459){ref-type="app"}). It is reported that NADPH could prevent oxidative stress in the cell. For example, NADPH reduces glutathione through glutathione reductase because NADPH could convert H~2~O~2~ into H~2~O by glutathione peroxidase. If NADPH is absent, the H~2~O~2~ would be converted to hydroxyl-free radicals to attack the cell \[[@B27-ijms-20-03459]\]. NADPH in the *P. italicum* might increase the fatty acid synthesis and oxidation resistance that may improve the defense during treated MNQ.

The stress condition tends to disrupt cell and organelle membranes and cause an ionic imbalance that stimulates the generation of reactive oxygen species (ROS) \[[@B29-ijms-20-03459]\]. The generation of ROS leads to apoptosis \[[@B30-ijms-20-03459]\]. Previous studies indicated that the antioxidant proteins were the first cellular defense against the oxidative stress. Glutathione transferase and dioxygenases may be related to the response of the fungus to oxidative stress caused by an ROS increase and ATP production \[[@B31-ijms-20-03459]\]. Our proteomics analysis revealed that MNQ treatment up-regulated seven oxidative stress related proteins including catalase (CAT), acyl transferase, glutathione synthetase carboxymuconolactone decarboxylase, tRNA-dihydrouridine (47) synthase \[NAD(P)(+)\], polyketide synthase, and aldolase-type TIM barrel ([Table 2](#ijms-20-03459-t002){ref-type="table"}). Antioxidant enzymes such as CAT was up-regulated when exposed to MNQ, which shows its important role in detoxification of ROS. In addition, antioxidant enzymes against ROS, such as peroxidase and alcohol dehydrogenase were also up-regulated, but the expression difference did not meet the significance criteria when exposed to MNQ stress as compared to the control group ([Table S1](#app1-ijms-20-03459){ref-type="app"}). Glutathione in fungi and some bacteria is an important antioxidant with a capability of preventing damage to important cellular constituents caused by ROS \[[@B32-ijms-20-03459]\]. Glutathione as a substrate, is also contributed to the regeneration of other antioxidants \[[@B33-ijms-20-03459]\]. Glutathione biosynthesis involves two sequential ATP dependent reactions, and is mediated by two enzymes γ-glutamylcysteine synthetase and glutathione synthetase (GS). Energy generation enhanced and GS increased 1.09-fold meant that glutathione increased in the treatment group. We hypothesized that the change of energy generation, NADPH supply, and oxidative stress affected the cell growth and mycelial morphology that was also confirmed by the *P. italicum* mycelial growth curve and microscopic analyses ([Figure 2](#ijms-20-03459-f002){ref-type="fig"} and [Figure 4](#ijms-20-03459-f004){ref-type="fig"}).

Among the pentose phosphate pathway (PPP), two enzymes called ribulose-phosphate 3-epimerase (RPE) and xylulose 5-phosphate were up-regulated. RPE can play a vital role in the development of a pool of NADPH, in the PPP that can convert monosaccharides, such as glucose, into the nucleotide precursor of pentose sugars. In addition, RPE can convert the ribulose-5-phosphate into xylulose 5-phosphate in the Calvin cycle \[[@B34-ijms-20-03459]\]. RPE was identified with reversibly oxidized cysteines, which was another enzyme that uses ribulose-5-phosphate as the substrate. We found other published sources that reported the rpe (ribulose phosphate 3-epimerase gene)-disrupted mutant resulted in low cell growth and low inosine production on glucose and on gluconate \[[@B35-ijms-20-03459]\]. Furthermore, RPE was up-regulated significantly, which suggests that PPP was significantly active in the treatment group. This pathway has been suggested as a drug target in trypanosomes \[[@B34-ijms-20-03459]\].

According to the above analysis, we speculated that MNQ inhibited the growth of *P. italicum* by affecting the generation of energy and NADPH, which, thereby, affects the synthesis of fatty acids and amino acids. Meanwhile, PPP may be the target of MNQ for *P. italicum*, but the actual situation still needs to be further investigated.

4. Materials and Methods {#sec4-ijms-20-03459}
========================

4.1. Microorganism and Medium {#sec4dot1-ijms-20-03459}
-----------------------------

*P. italicum* was provided by the South China Botanical Garden, Chinese Academy of Sciences (Guangzhou, China). *P. italicum* was cultured on potato dextrose agar (PDA, potato 200 g/L, agar 20 g/L, and dextrose 20 g/L) or potato dextrose broth (PDB, potato 200 g/L and dextrose 20 g/L).

4.2. MNQ Inhibition of P. italicum {#sec4dot2-ijms-20-03459}
----------------------------------

### 4.2.1. Antifungal Assay {#sec4dot2dot1-ijms-20-03459}

The effects of MNQ on mycelial growth were measured as described by Myresiotis et al. \[[@B36-ijms-20-03459]\]. MNQ was suspended in DMSO and the stock solution of MNQ (10,000 μg/mL) was added to the PDA media (50 mL) contained in conical flasks to obtain the desired concentrations of MNQ (0, 1.0, 2.0, 4.0, and 6.0 μg/mL) in the media. The medium was poured into a set of three Petri dishes (90 mm in diameter) under aseptic conditions. Then the plates were placed under UV light for solidification of the media. Meanwhile, we transferred the mycelia of *P. italicum* grown on PDA (about 7 days) to PDB in order to obtain conidial suspensions (about 1 × 10^5^ CFU/mL). After that, 1 μL of *P. italicum* (1 × 10^5^ CFU/mL conidial suspensions) were transferred to the center of the PDA plates. PDA media amended with DMSO (20 μL) was used as the control. Each treatment in the experiment had three replicate plates, and was repeated twice. All cultivations were carried out at 28 °C. The inhibition of mycelial growth rate (%) was calculated using the following formula \[[@B37-ijms-20-03459]\]. where C and T were the mean mycelium colony diameters of the control and the treatment and I was the inhibition of the mycelial growth rate (%).

### 4.2.2. Minimum Inhibitory Concentration (MIC) Tests {#sec4dot2dot2-ijms-20-03459}

The effects of MNQ on *P. italicum* were performed with a minimum inhibitory concentration (MIC) value \[[@B38-ijms-20-03459]\]. MNQ was tested against *P. italicum* at different concentrations of 40.0, 20.0, 10.0, 5.0, 2.5, 1.25, 0.625, and 0.3125 μg/mL. The stock solution of MNQ (10,000 μg/mL) was first diluted to the highest concentration (40 μg/mL), and then serial two-fold dilution was made in a concentration range from 40.0 to 0.3125 μg/mL. The solutions poured into 50 mL conical flasks containing melted PDA medium. Then the medium was poured into a set of three Petri dishes (60 mm in diameter) under aseptic conditions. The plates were placed under UV light for solidification of the media. After solidification, 20 μL of conidial suspensions (about 1 × 10^5^ CFU/mL) were then smeared evenly onto the surface of the plates, aseptically. Lastly, all the culture plates were incubated at 28 °C for 48 h. Each treatment had three replicate plates, and the experiment was repeated twice.

4.3. Cell Culture and MNQ Treatment {#sec4dot3-ijms-20-03459}
-----------------------------------

Two milliliters of the conidial suspensions (about 1 × 10^5^ CFU/mL) were added into a 1000 mL conical flask containing 200 mL of PDB. Then all the cultivations were carried out on a rotary shaker at 140 rpm at 28 °C. After two days of incubation, 40 µL of MNQ stock solution (10,000 μg/mL) was added to the three bottles of cultivations as the treatment group (2 µg/mL of MNQ), aseptically. The cultivations without dosing any MNQ were considered to be the control group. Then, all cultivations were carried out on a rotary shaker at 140 rpm at 28 °C for another 2 days. For the treatment group, 2.0 μg/mL of MNQ was used in this work, and, without dosing, any MNQ was considered to be the control group. Three biological replicates were carried out for each condition. In this cases, sub-MIC doses of MNQ were applied to *P. italicum*, in order to impose stress to the cells but not induce non-specific effects associated with cell death \[[@B15-ijms-20-03459]\]. The *P. italicum* mycelia were harvested after four days of cultivation. The mycelia were collected by centrifugation after being washed in three 5-minute steps with 0.1 M PBS (pH 7.4). Part of the mycelia is used for microscopic observation and part of it is used for proteomics analysis.

4.4. Label-Free Quantitative Proteomics {#sec4dot4-ijms-20-03459}
---------------------------------------

### 4.4.1. Sample Preparation {#sec4dot4dot1-ijms-20-03459}

The mycelia were obtained through centrifugation at 5000 g for 3 min, and then washed with PBS buffer three times. The cell pellets were suspended on ice in 200 μL of lysis buffer (4% SDS, 100 mM DTT, 150 mM TrisHCl, pH 8.0). Cells were disrupted by a homogenizer agitated (Fastprep-24^®^, MP Biomedical, USA), and the lysates were boiled for 5 min. The samples were further homogenized using ultra-sonication, and then boiled for another 5 min. Undissolved cellular debris were removed by centrifugation at 14,000 rpm for 15 min and the supernatants were collected for further investigation and quantified with a BCA Protein Assay Kit (Bio-Rad, Hercules, CA, USA).

### 4.4.2. Protein Digestion {#sec4dot4dot2-ijms-20-03459}

Digestion of protein (250 μg for each sample) was performed according to the FASP procedure \[[@B39-ijms-20-03459]\]. In brief, the detergent, DTT, and low-molecular-weight constituents were removed using a 200 μL UA buffer (8 M Urea, 150 mM Tris-HCl pH 8.0) by repeated ultra-filtration (Microcon units, 30 kDa) facilitated by centrifugation. In order to reduce cysteine residues, 100 μL 0.05 M iodoacetamide added in UA buffer was to block reduced cysteine residues. These samples were incubated in the dark within 20 min. The filter was washed with a 100 μL UA buffer three times and then with a 100 μL 25 mM NH~4~HCO~3~ two times. The resulting proteins were digested using 3 μg trypsin (Promega, Madison, WI, USA) in 40 μL 25 mM NH~4~HCO~3~ overnight at 37 °C, and the resulting peptides were collected as a filtrate. The peptide content was estimated by a UV light spectral density of 280 nm.

### 4.4.3. Liquid Chromatography (LC)-Electrospray Ionization (ESI) Tandem MS (MS/MS) Analysis {#sec4dot4dot3-ijms-20-03459}

The peptide in each sample was desalted on C18 Cartridges (Sigma, St. Louis, MO, USA). It was then concentrated by a vacuum centrifugation and was reconstituted in 40 µL of 0.1% (*v/v*) trifluoroacetic acid. MS experiments were performed on a Q Exactive mass spectrometer coupled to an Easy nLC (ThermoFisher Scientific, Waltham, MA, USA). An aliquot comprising 5 μg peptide was loaded onto a C18-reversed phase column (Thermo Scientific Easy Column, 10 cm long, 75 μm inner diameter, 3 μm resin) in buffer A (2% acetonitrile and 0.1% formic acid) and was separated with a linear gradient of buffer B (80% acetonitrile and 0.1% Formic acid) at a flow rate of 250 nL/min controlled by an IntelliFlow technology over 120 min. A data-dependent top 10 method dynamically choosing the most abundant precursor ions from the survey scan (300--1800 m/z) for HCD fragmentation was carried out to obtain the MS data. Determination of the target value is on the basis of the predictive Automatic Gain Control (pAGC). Each sample was carried out in MS experiments three times.

### 4.4.4. Sequence Database Searching and Data Analysis {#sec4dot4dot4-ijms-20-03459}

The MS data were searched against the UniProtKB *P. italicum* database and were analyzed using a MaxQuant software (version 1.3.0.5). An initial search was set at a precursor mass window of 6 ppm. An enzymatic cleavage rule of Trypsin/P and a maximum of two missed cleavage sites were perform in this research. Cysteines carbamidomethylation was defined as fixed modification. Meanwhile, protein N-terminal acetylation and methionine oxidation were defined as variable modifications. The cutoff of global FDR for peptide and protein identification was set to 0.01. Label-free quantification was performed in MaxQuant, as preceding studies reported \[[@B40-ijms-20-03459]\]. Protein abundance was calculated on the basis of the normalized spectral protein intensity (LFQ intensity). The fellow data of the target proteins were retrieved from the UniProtKB database in batches. Each query sequence was retrieved and loaded into Blast2GO (version 2.7.2) for GO annotation and KEGG pathway analysis.

The protein sequences of the DEPs were in batches retrieved in the FASTA format from UniProtKB database. The retrieved sequences were searched from the SwissProt database using the NCBI BLAST+ client software to find homologue sequences from which the functional annotation can be transferred to the studied sequences. The top 10 blast hits in each query sequence with E-value less than 1e^−3^ were retrieved and loaded into Blast2GO \[[@B41-ijms-20-03459]\] for GO mapping and annotation. An annotation configuration with an E-value filter of 1e^−6^, default gradual EC weights, a GO weight of 5, and an annotation cutoff of 75 were chosen. The unannotated sequences were then reannotated with more permissive parameters. Then, we used the looser parameters to reannotate the unannotated sequence. Lastly, the unannotated sequences and sequences without BLAST hits were then selected to go through an InterProScan \[[@B42-ijms-20-03459]\] against EBI databases to retrieve functional annotations of protein and merge the InterProScan GO terms to the annotation set. As for the KEGG pathway analysis, the FASTA protein sequences of DEPs were blasted against the online KEGG database (<http://geneontology.org/>) to retrieve their KOs and were, subsequently, mapped to pathways in KEGG \[[@B43-ijms-20-03459]\].

4.5. Parallel Reaction Monitoring (PRM) Analysis {#sec4dot5-ijms-20-03459}
------------------------------------------------

In order to confirm the protein expression levels identified by label-free quantitative proteomics analysis, we further quantified the expression levels of selected proteins. Based on femtomole peptide/microgram total protein, samples were added with known amounts of each standard to determine the number of respective proteins in the sample. We used parallel reaction monitoring (PRM) to analyzed samples \[[@B44-ijms-20-03459],[@B45-ijms-20-03459]\]. All fragment ions were quantified in the orbitrap after each precursor ion (light and heavy masses) was selected by the fragmented quadrupole \[[@B46-ijms-20-03459]\]. Skyline (MacCoss Lab Software version 3.1) was used for data analysis to estimate peptide signal intensity. According to the ratio of the heavy peptide standards that were added in the known quantity, peptide concentration was calculated. Ion activation/dissociation was acted at a normalized collision energy of 27 in the HCD collision cell \[[@B47-ijms-20-03459]\]. Skyline were used to analyzed the raw data where signal intensities for individual peptide sequences for each of the significantly changed proteins were quantified relative to every sample and normalized to a standard reference.

4.6. Statistical Analysis {#sec4dot6-ijms-20-03459}
-------------------------

Statistical analysis was performed with a one-way ANOVA in Origin 6.1 software. The statistical analysis (Student's t-test and G-test) was conducted by PepC44 on two conditions: the treatment group and the control group. The DEPs were filtered by the following cutoff: up-regulated \> 2.0-fold or down-regulated \< 0.5-fold, *p* \< 0.05.

5. Conclusions {#sec5-ijms-20-03459}
==============

Overall, our present investigation revealed that MNQ had a significant anti-*P. italicum* activity with a MIC value of 5.0 µg/mL. The label-free protein profiling under different MNQ conditions identified a total of 3037 proteins in the control group and the treatment group. Among them, there were 129 DEPs, including 19 up-regulated proteins, 26 down-regulated proteins, and 67 proteins that were specific for the treatment group and another 17 proteins that were specific for the control group. Functional characterization by GO and KEGG enrichment results suggests that the DEPs are mainly related to energy generation, the NADPH supply, oxidative stress, and PPP. The PRM assay confirmed that the expression of the nitroreductase family protein, monooxygenase, and cytochrome P450 are significantly down-regulated in the *P. italicum* with MNQ treatment. Based on the microscopic observation and the proteomics results mentioned above, we speculated that the proteins associated with energy production, NADPH supply, and other functions in *P. italicum* were altered to reduce the damage caused by MNQ. Thus, these findings will contribute to further understanding of the possible new molecular action of MNQ against *P. italicum*.

Supplementary materials can be found at <https://www.mdpi.com/1422-0067/20/14/3459/s1>. Table S1. The proteins identified in the treatment group and the control group. Figure S1. Effects of MNQ against *P. italicum* in different concentrations. Figure S2. Top 10 pathway enrichments of the identified DEPs.
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Click here for additional data file.
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![Inhibition of mycelial growth of *P. italicum* by MNQ.](ijms-20-03459-g002){#ijms-20-03459-f002}

![Light microscopy observation of *P. italicum* mycelial morphology (96 h). (**a**) *P. italicum* in the control group, (**b**) and (**c**) *P. italicum* in the treatment group (magnification is 400 times).](ijms-20-03459-g003){#ijms-20-03459-f003}

![DEPs in different groups. (**a**) Volcano plot of DEPs, I-T was the treatment group. I-C was the control group. (**b**) Venn diagram of proteins in different groups.](ijms-20-03459-g004){#ijms-20-03459-f004}

![Hierarchical cluster analysis was conducted for all the DEPs. I-T was the treatment group. I-C was the control group. The numbers were the protein ID and could search in [Table S1](#app1-ijms-20-03459){ref-type="app"}.](ijms-20-03459-g005){#ijms-20-03459-f005}

![Statistical results of different functional annotations.](ijms-20-03459-g006){#ijms-20-03459-f006}
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GO annotation for the DEPs.
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###### 

Effect of different MNQ concentrations on mycelial growth of *P. italicum* ^1^.

  Concentration (μg/mL)   Mycelial Diameter (mm)   I (%)
  ----------------------- ------------------------ ------------------
  CK                      33.83 ± 0.54 ^a^         \--
  0.0                     32.67 ± 0.56 ^a^         3.45 ± 1.65 ^c^
  1.0                     30.83 ± 0.54 ^a^         8.87 ± 1.60 ^c^
  2.0                     17.33 ± 2.30 ^b^         48.77 ± 6.81 ^b^
  4.0                     2.33 ± 0.80 ^c^          93.10 ± 2.37 ^a^
  6.0                     0.83 ± 0.17 ^c^          97.54 ± 0.49 ^a^

^1^ Mycelial growth was measured after incubation at 28 °C for seven days. The date presented are the means ± S.E. (*n* = 6). ^a--c^ The column with different lowercase letters between different concentrations indicates significant differences, according to Duncan's test (*p* \< 0.05).
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###### 

The DEPs in different groups.

  -------------------------------------------------------------------------------------------------------------------------------------------------
  Protein      Protein Name                                                                      Gene Name     Fold Changes ^1^   GO Category ^2^
  ------------ --------------------------------------------------------------------------------- ------------- ------------------ -----------------
  A0A0A2KI00   Uncharacterized protein                                                           PITC_013530   9.66               MF

  A0A0A2KQ56   Uncharacterized protein                                                           PITC_017440   5.80               

  A0A0A2LA04   Ribulose-phosphate 3-epimerase                                                    PITC_011800   3.84               BP, MF

  A0A0A2KBU2   Hydrophobin                                                                       PITC_015600   3.83               MF, CC

  A0A0A2KT64   Uncharacterized protein                                                           PITC_065480   3.15               

  A0A0A2KL24   Uncharacterized protein                                                           PITC_064010   2.99               

  A0A0A2LAT4   Uncharacterized protein                                                           PITC_037340   2.79               

  A0A0A2KR85   Uncharacterized protein                                                           PITC_014180   2.76               

  A0A0A2KVZ5   Uncharacterized protein                                                           PITC_028500   2.72               

  A0A0A2KMP8   Uncharacterized protein                                                           PITC_017400   2.67               

  A0A0A2L522   Mitochondrial carrier protein                                                     PITC_038210   2.51               MF, CC

  A0A0A2KX25   Uncharacterized protein                                                           PITC_051360   2.37               

  A0A0A2L8T3   Uncharacterized protein                                                           PITC_098640   2.32               

  A0A0A2L2N9   HEAT, type 2                                                                      PITC_085160   2.10               

  A0A0A2L2V7   Acyl-CoA dehydrogenase, N-terminal                                                PITC_066160   2.10               MF

  A0A0A2LCB9   Glycoside hydrolase, family 28                                                    PITC_005000   2.10               BP, MF, CC

  A0A0A2LAG1   Xylulose 5-phosphate/Fructose 6-phosphate phosphoketolase, N-terminal             PITC_003850   2.10               BP, MF

  A0A0A2L8I5   Glucose-repressible protein Grg1                                                  PITC_061580   2.05               

  A0A0A2L934   Polyketide synthase, enoylreductase                                               PITC_030400   2.04               MF

  A0A0A2LBT9   CDR ABC transporter                                                               PITC_091640   0.49               MF, CC

  A0A0A2KM09   ATPase, AAA-type, core                                                            PITC_028850   0.48               MF

  A0A0A2KZ16   Mandelate racemase/muconate lactonizing enzyme                                    PITC_098150   0.48               BP, MF

  A0A0A2KNF6   Cytochrome P450                                                                   PITC_065080   0.47               BP, MF

  A0A0A2LD14   Short-chain dehydrogenase/reductase SDR                                           PITC_006840   0.46               

  A0A0A2LAZ8   Uncharacterized protein                                                           PITC_023560   0.45               CC

  A0A0A2KLM8   Aldo/keto reductase                                                               PITC_048920   0.43               MF

  A0A0A2L925   ABC transporter, integral membrane type 1                                         PITC_030250   0.41               MF, CC

  A0A0A2L7S7   Reverse transcriptase                                                             PITC_011060   0.38               MF

  A0A0A2L743   Uncharacterized protein                                                           PITC_032240   0.35               MF

  A0A0A2KIE8   Male sterility, NAD-binding                                                       PITC_056110   0.34               MF

  A0A0A2LCN6   Short-chain dehydrogenase/reductase SDR                                           PITC_019130   0.31               

  A0A0A2LGP0   Carbon-nitrogen hydrolase                                                         PITC_029870   0.30               BP, MF

  A0A0A2KZU8   Peptidase M20                                                                     PITC_086250   0.23               MF

  A0A0A2LFP8   O-methyltransferase, family 3                                                     PITC_025440   0.21               MF

  A0A0A2L830   ThiJ/PfpI                                                                         PITC_001680   0.14               

  A0A0A2L1V6   N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D                       PITC_051890   0.12               MF

  A0A0A2LCF5   Acyl-transferase/acyl-hydrolase/lysophospholipase                                 PITC_005350   0.08               MF

  A0A0A2L5Z5   Uncharacterized protein                                                           PITC_002480   0.08               

  A0A0A2L3A1   Uncharacterized protein                                                           PITC_038310   0.07               

  A0A0A2LCE5   Uncharacterized protein                                                           PITC_005250   0.06               

  A0A0A2LAC2   Uncharacterized protein                                                           PITC_005360   0.04               

  A0A0A2LKC5   Monooxygenase, FAD-binding                                                        PITC_005370   0.03               MF, CC

  A0A0A2L9W9   Uncharacterized protein                                                           PITC_005390   0.03               BP, MF

  A0A0A2KD20   Uncharacterized protein                                                           PITC_008180   0.03               BP, MF

  A0A0A2LCH9   Uncharacterized protein                                                           PITC_005280   0.03               

  A0A0A2LEG0   E3 ubiquitin protein ligase                                                       PITC_068020   \+                 BP, MF, CC

  A0A0A2KL74   Uncharacterized protein                                                           PITC_064410   \+                 

  A0A0A2L3H1   Kinetochore-Ndc80 subunit Spc24                                                   PITC_084180   \+                 

  A0A0A2LNS4   Zinc finger, RING-type                                                            PITC_024830   \+                 MF

  A0A0A2KNZ0   Translation elongation factor EF1B/ribosomal protein S6                           PITC_014590   \+                 MF, CC

  A0A0A2KWT6   Ribosome-releasing factor 2, mitochondrial                                        MEF2          \+                 BP, MF, CC

  A0A0A2LC54   Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2                            PITC_059690   \+                 BP, MF

  A0A0A2LG71   Pectin lyase fold/virulence factor                                                PITC_050450   \+                 MF

  A0A0A2L5T7   Uncharacterized protein                                                           PITC_001930   \+                 BP

  A0A0A2K9T6   Uncharacterized conserved protein UCP022603                                       PITC_093160   \+                 

  A0A0A2K9G7   Glycoside hydrolase, superfamily                                                  PITC_049080   \+                 BP, MF

  A0A0A2LF07   CheY-like superfamily                                                             PITC_061050   \+                 MF

  A0A0A2LN85   Taxilin family                                                                    PITC_010570   \+                 MF

  A0A0A2KY31   Beta-glucosidase                                                                  PITC_028190   \+                 BP, MF

  A0A0A2KE07   Chromatin-remodeling complex, RSC SWI/SNF subunit Rsc7/Swp82                      PITC_055960   \+                 

  A0A0A2LB02   RNA polymerase II subunit A                                                       PITC_092370   \+                 BP, MF, CC

  A0A0A2L857   Transcription factor, MADS-box                                                    PITC_001660   \+                 BP, MF, CC

  A0A0A2L6J4   Neurolysin/Thimet oligopeptidase, N-terminal                                      PITC_084000   \+                 BP, MF, CC

  A0A0A2KT14   Monopolin complex, subunit Csm1/Pcs1                                              PITC_066000   \+                 

  A0A0A2LE82   Uncharacterized protein                                                           PITC_037500   \+                 

  A0A0A2LBD7   Sof1-like protein                                                                 PITC_089150   \+                 

  A0A0A2L5N2   Striatin, N-terminal                                                              PITC_021600   \+                 

  A0A0A2L4U0   tRNA-dihydrouridine(47)synthase\                                                  PITC_047170   \+                 MF
               \[NAD(P)(+)\]                                                                                                      

  A0A0A2L4G7   Phosphatidylserine decarboxylase proenzyme 1, mitochondrial                       PSD1          \+                 BP, MF, CC

  A0A0A2KS93   BolA protein                                                                      PITC_042910   \+                 

  A0A0A2LEA3   Uncharacterized protein                                                           PITC_034190   \+                 

  A0A0A2KWV6   Sensitivity to Red Light Reduced-like, SRR1                                       PITC_077860   \+                 

  A0A0A2L4C5   Poly(A) polymerase                                                                PITC_097130   \+                 BP, MF, CC

  A0A0A2L1S8   Heme-containing dehydratase                                                       PITC_040090   \+                 

  A0A0A2L7N4   Winged helix-turn-helix transcription repressor DNA-binding                       PITC_006550   \+                 BP, MF, CC

  A0A0A2KI48   Aldolase-type TIM barrel                                                          PITC_009330   \+                 MF

  A0A0A2KWA6   Putative domain, di-copper center                                                 PITC_096580   \+                 MF

  A0A0A2LFQ2   Uncharacterized protein                                                           PITC_025560   \+                 CC

  A0A0A2LAP4   Uncharacterized protein                                                           PITC_036940   \+                 

  A0A0A2KHA2   DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal   PITC_071920   \+                 BP, MF

  A0A0A2LFW6   Catalase, mono-functional, heme-containing                                        PITC_041140   \+                 BP, MF

  A0A0A2L4V0   Sas10/Utp3/C1D                                                                    PITC_084500   \+                 

  A0A0A2KMY7   PfkB                                                                              PITC_046750   \+                 

  A0A0A2L452   Blastomyces yeast-phase-specific protein                                          PITC_083580   \+                 

  A0A0A2LFY2   Outer membrane protein, IML2, mitochondrial/Tetratricopeptide repeat protein 39   PITC_041270   \+                 CC

  A0A0A2L4F0   Vacuolar protein sorting-associated protein 28                                    PITC_032200   \+                 BP, CC

  A0A0A2KNJ7   Ferritin                                                                          PITC_095310   \+                 BP, MF, CC

  A0A0A2KCE3   Uncharacterized protein                                                           PITC_093200   \+                 

  A0A0A2L328   CheY-like superfamily                                                             PITC_099880   \+                 BP, MF

  A0A0A2KWF5   Ribosomal protein L53, mitochondrial                                              PITC_063020   \+                 CC

  A0A0A2LGC1   Uncharacterized protein                                                           PITC_036010   \+                 

  A0A0A2KAJ2   Sec1-like protein                                                                 PITC_055020   \+                 BP, CC

  A0A0A2KLU4   H/ACA ribonucleoprotein complex, subunit Nop10                                    PITC_015880   \+                 BP, MF

  A0A0A2LB80   Uncharacterized protein                                                           PITC_088770   \+                 MF

  A0A0A2L283   Vacuole morphology and inheritance protein 14                                     PITC_085800   \+                 BP, CC

  A0A0A2LJG8   Uncharacterized protein                                                           PITC_091330   \+                 

  A0A0A2LDT3   Scytalone dehydratase                                                             PITC_055360   \+                 BP, MF

  A0A0A2KPK9   Alpha/gamma-adaptin-binding protein p34                                           PITC_045290   \+                 

  A0A0A2LF46   Glutamyl-tRNA(Gln) amido-transferase subunit B, mitochondrial                     PITC_061230   \+                 BP, MF, CC

  A0A0A2LDQ9   Uncharacterized protein                                                           PITC_055380   \+                 

  A0A0A2KLL9   Acyl-transferase/acyl-hydrolase/lysophospholipase                                 PITC_048820   \+                 MF

  A0A0A2KPR9   Uncharacterized protein                                                           PITC_054110   \+                 CC

  A0A0A2KYQ5   Magnesium transporter                                                             PITC_061420   \+                 CC

  A0A0A2KM68   Uncharacterized protein                                                           PITC_079240   \+                 

  A0A0A2LE28   Carboxymuconolactone decarboxylase                                                PITC_044010   \+                 MF

  A0A0A2LBC3   Uncharacterized protein                                                           PITC_016760   \+                 

  A0A0A2LPW9   Uncharacterized protein                                                           PITC_059180   \+                 

  A0A0A2KYR5   Uncharacterized protein                                                           PITC_014450   \+                 

  A0A0A2KPB6   Exon junction complex, Pym                                                        PITC_045720   \+                 BP

  A0A0A2L3C0   Uncharacterized protein                                                           PITC_002320   \+                 

  A0A0A2LDR6   Translation Initiation factor eIF-4e                                              PITC_055210   \+                 MF, CC

  A0A0A2L3Q9   Uncharacterized protein                                                           PITC_035540   \+                 

  A0A0A2K7Z3   RTA-like protein                                                                  PITC_013070   \--                CC

  A0A0A2K9K0   Uncharacterized protein                                                           PITC_049430   \--                CC

  A0A0A2KC81   Zinc finger, CCCH-type                                                            PITC_079160   \--                MF

  A0A0A2KRX9   FAD dependent oxidoreductase                                                      PITC_020210   \--                MF

  A0A0A2KTM9   AP-3 complex subunit delta                                                        PITC_064680   \--                BP, CC

  A0A0A2KTQ5   TRAM1-like protein                                                                PITC_000730   \--                CC

  A0A0A2KY77   MAP kinase                                                                        PITC_057580   \--                BP, MF, CC

  A0A0A2L001   Uncharacterized protein                                                           PITC_075040   \--                MF, CC

  A0A0A2L1F3   Membrane-associated, eicosanoid/glutathione metabolism protein (MAPEG)            PITC_035700   \--                CC

  A0A0A2L3U6   Uncharacterized protein                                                           PITC_083660   \--                MF

  A0A0A2L4J0   RNA recognition motif domain, eukaryote                                           PITC_097790   \--                BP, MF, CC

  A0A0A2L843   Serine hydrolase FSH                                                              PITC_001510   \--                MF

  A0A0A2L8X0   Glutamyl-tRNA synthetase, class Ib, archaeal/eukaryotic cytosolic                 PITC_073010   \--                BP, MF, CC

  A0A0A2L929   Acyl-CoA dehydrogenase, N-terminal                                                PITC_030080   \--                MF

  A0A0A2L9E5   Major facilitator superfamily domain, general substrate transporter               PITC_090610   \--                BP, CC

  A0A0A2LCH4   Major facilitator superfamily domain, general substrate transporter               PITC_004620   \--                MF, CC

  A0A0A2LEL6   Tetratricopeptide-like helical                                                    PITC_067660   \--                MF
  -------------------------------------------------------------------------------------------------------------------------------------------------

^1^ Up-regulated proteins are highlighted in red. Down-regulated proteins are highlighted in green. "+" stands for only detected in treatment group and "\--" stands for only detected in the control group. ^2^ BP was biological process, MF was molecular function, CC was cellular component.
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###### 

Numbers of DEPs in the treatment group compared with the control group.

  Comparisons                           Number of Involved Proteins   
  ------------------------------------- ----------------------------- ----
  Significantly changing in abundance   19                            26
  Newly arising/undetectable ^1^        67                            17

^1^ The proteins newly arising/undetectable in the treatment group were also treated as significantly up-regulated/down-regulated.
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###### 

Pathways encompassed by the DEPs ^1^.

  ----------------------------------------------------------------------------------------------------------------------------------
  Pathway                                          Protein Name
  ------------------------------------------------ ---------------------------------------------------------------------------------
  Dioxin degradation                               Monooxygenase, FAD-binding

  Polycyclic aromatic hydrocarbon degradation      Monooxygenase, FAD-binding

  Linoleic acid metabolism                         Cytochrome P450

  Betalain biosynthesis                            Putative domain, di-copper center

  Sphingolipid metabolism                          TRAM1-like protein

  Mineral absorption                               Ferritin

  Longevity regulating pathway                     Catalase, mono-functional, heme-containing\
                                                   Translation Initiation factor eIF-4e

  Pentose and glucuronate interconversions         Ribulose-phosphate 3-epimerase\
                                                   Glycoside hydrolase, family 28

  MAPK signaling pathway - yeast                   Transcription factor, MADS-box;\
                                                   Catalase, mono-functional, heme-containing;\
                                                   MAP kinase

  mRNA surveillance pathway                        RNA polymerase II subunit A;\
                                                   Poly(A) polymerase;\
                                                   Exon junction complex, Pym

  Carbon fixation in photosynthetic organisms      Ribulose-phosphate 3-epimerase;\
                                                   Xylulose 5-phosphate/Fructose 6-phosphate phosphoketolase, N-terminal

  Pentose phosphate pathway                        Ribulose-phosphate 3-epimerase;\
                                                   Xylulose 5-phosphate/Fructose 6-phosphate phosphoketolase, N-terminal

  Phenylpropanoid biosynthesis                     Beta-glucosidase

  Naphthalene degradation                          Monooxygenase, FAD-binding

  MAPK signaling pathway - plant                   Catalase, mono-functional, heme-containing

  Chemical carcinogenesis                          Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein

  Mismatch repair                                  DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal

  Ferroptosis                                      Ferritin

  Isoquinoline alkaloid biosynthesis               Putative domain, di-copper center

  Cyanoamino acid metabolism                       Beta-glucosidase

  EGFR tyrosine kinase inhibitor resistance        Translation Initiation factor eIF-4e

  Drug metabolism - cytochrome P450                Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein

  Amyotrophic lateral sclerosis (ALS)              Catalase, mono-functional, heme-containing

  DNA replication                                  DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal

  Metabolism of xenobiotics by cytochrome P450     Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein

  Melanogenesis                                    Putative domain, di-copper centre

  Platinum drug resistance                         Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein

  Galactose metabolism                             Mandelate racemase/muconate lactonizing enzyme

  Two-component system                             MAP kinase

  MAPK signaling pathway - fly                     Striatin, N-terminal

  Nucleotide excision repair                       DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal

  HIF-1 signaling pathway                          Translation Initiation factor eIF-4e

  Hepatocellular carcinoma                         Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein

  Lysosome                                         AP-3 complex subunit delta

  FoxO signaling pathway                           Catalase, mono-functional, heme-containing

  Fluid shear stress and atherosclerosis           Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein

  Longevity regulating pathway - worm              Catalase, mono-functional, heme-containing

  Drug metabolism - other enzymes                  Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein

  Necroptosis                                      Ferritin

  Longevity regulating pathway--multiple species   Catalase, mono-functional, heme-containing

  Human T-cell leukemia virus 1 infection          Vacuole morphology and inheritance protein 14

  Glutathione metabolism                           Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein

  Tyrosine metabolism                              Putative domain, di-copper center

  Tryptophan metabolism                            Catalase, mono-functional, heme-containing

  Peroxisome                                       Catalase, mono-functional, heme-containing

  Glycerophospholipid metabolism                   Phosphatidylserine decarboxylase proenzyme 1, mitochondrial

  Ribosome biogenesis in eukaryotes                HEAT, type 2,H/ACA ribonucleoprotein complex, subunit Nop10

  Insulin signaling pathway                        Translation Initiation factor eIF-4e

  Starch and sucrose metabolism                    Beta-glucosidase

  PI3K-Akt signaling pathway                       Translation Initiation factor eIF-4e

  mTOR signaling pathway                           Translation Initiation factor eIF-4e

  Viral carcinogenesis                             Vacuole morphology and inheritance protein 14

  Pathways in cancer                               Membrane-associated, eicosanoid/glutathione metabolism (MAPEG) protein

  Amino sugar and nucleotide sugar metabolism      Glycoside hydrolase, superfamily

  Glyoxylate and dicarboxylate metabolism          Catalase, mono-functional, heme-containing

  Aminoacyl-tRNA biosynthesis                      Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial

  RNA transport                                    Exon junction complex, Pym;\
                                                   Translation Initiation factor eIF-4e

  Autophagy--yeast                                 Sec1-like protein

  Endocytosis                                      Vacuolar protein sorting-associated protein 28

  Spliceosome                                      Uncharacterized protein
  ----------------------------------------------------------------------------------------------------------------------------------

^1^ Up-regulated proteins are highlighted in red. Down-regulated proteins are highlighted in green.
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###### 

Comparison of the proteomics result and the PRM result of the three candidate proteins.

  ----------------------------------------------------------------------------------------------------------------
  Protein Name                         Gene Name     Signature Peptides   Proteomics Result ^1^   PRM Result ^2^
  ------------------------------------ ------------- -------------------- ----------------------- ----------------
  Nitro-reductase family protein ^3^   PITC_008180   LGPLLQSHK\           0.03                    0.05
                                                     SISPALWEK                                    

  Cytochrome P450                      PITC_065080   AVLSDAVALVR          0.47                    0.35

  Monooxygenase                        PITC_005370   GALEEALQTYSGVR\      0.03                    0.16
                                                     QLENYDEVDDK\                                 
                                                     SDANTSNAYWNGFHPR                             
  ----------------------------------------------------------------------------------------------------------------

^1^ Fold changes of protein abundance in proteomics result. Down-regulated proteins are highlighted in green. ^2^ Fold changes of protein abundance in PRM result. ^3^ Nitroreductase family protein (from *Metarhizium brunneum*, 90.4%).
